Position in HALO
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$571,292
+$204,388 QoQ
Shares Held
7,299
+28.6% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#373
of 664 holders
Holding Since
Jun 2020
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in HALO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Banque Cantonale Vaudoise holds $18,384,772 across 26 Biotechnology names. HALO ranks #7 (3.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
10,020 | $4,977,234 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
7,303 | $2,198,422 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,883 | $1,797,665 | |
| 4 | CRSP |
CRISPR Therapeutics AG
|
24,065 | $1,312,505 | |
| 5 | INSM |
INSMED Inc
|
12,070 | $1,286,903 | |
| 6 | BMRN |
Biomarin Pharmaceutical Inc
|
16,000 | $915,520 | |
| 7 | HALO |
Halozyme Therapeutics, Inc.
This page
|
7,299 | $571,292 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
1,052 | $564,871 |
All Filings in HALO
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $571,292 | 7,299 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $366,904 | 5,677 | Shares | Sole | 2026-04-20 | |
| 2020-06-30 | $26,756 | 998 | Shares | Sole | 2020-07-22 | |
| No filing history on record for this holder in this stock. | ||||||